Smart Kem, Inc. SMTK
We take great care to ensure that the data presented and summarized in this overview for SmartKem, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in SMTK
Top Purchases
Top Sells
About SMTK
SmartKem, Inc. engages in the development of materials and processes for organic thin-film transistors backplanes for the manufacture of flexible electronics. Its transistor stacks are used in various applications, including bendable smart-phone displays, curved automotive displays, e-paper displays, wearables, fingerprint sensors, and printed biosensors. SmartKem, Inc. was founded in 2009 and is headquartered in Manchester, the United Kingdom.
Insider Transactions at SMTK
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 30
2024
|
Klaas De Boer Director |
BUY
Conversion of derivative security
|
Indirect |
5,715
+33.33%
|
-
|
|
Feb 12
2024
|
Ian Jenks Chairman & CEO |
SELL
Bona fide gift
|
Direct |
500
-4.54%
|
-
|
|
Feb 08
2024
|
Ian Jenks Chairman & CEO |
SELL
Bona fide gift
|
Direct |
7,200
-39.54%
|
-
|
|
Jan 31
2024
|
Klaas De Boer Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+50.0%
|
-
|
|
Jan 31
2024
|
Sriram Krishnamurthy Peruvemba Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+50.0%
|
-
|
|
Jan 31
2024
|
Simon Ogier Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100
+1.71%
|
-
|
|
Jan 31
2024
|
Barbra Keck Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100
+50.0%
|
-
|
|
Jan 31
2024
|
Ian Jenks Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100
+0.55%
|
-
|
|
Jan 31
2024
|
Beverley Brown Chief Scientist |
BUY
Grant, award, or other acquisition
|
Direct |
100
+50.0%
|
-
|
|
Jan 31
2024
|
Melisa Denis Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+50.0%
|
-
|
|
Jan 31
2024
|
Steven Denbaars Director |
BUY
Grant, award, or other acquisition
|
Direct |
100
+10.93%
|
-
|
|
Jan 27
2022
|
Simon P. King Director |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+15.16%
|
$2,000,000
$2.0 P/Share
|
|
Feb 23
2021
|
Ian Seth Jacobs |
SELL
Other acquisition or disposition
|
Direct |
50,000
-20.0%
|
-
|
|
Feb 23
2021
|
Mark N. Tompkins |
SELL
Other acquisition or disposition
|
Direct |
2,450,000
-51.58%
|
-
|
|
Feb 23
2021
|
Klaas De Boer Director |
BUY
Other acquisition or disposition
|
Indirect |
3,585,252
+50.0%
|
-
|
|
Feb 23
2021
|
Klaas De Boer Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+50.0%
|
$400,000
$2.0 P/Share
|
|
Feb 23
2021
|
Simon Ogier Chief Technology Officer |
BUY
Other acquisition or disposition
|
Direct |
198,087
+50.0%
|
-
|
|
Feb 23
2021
|
Ian Jenks Chairman & CEO |
BUY
Other acquisition or disposition
|
Direct |
633,880
+50.0%
|
-
|
|
Feb 23
2021
|
Robert Bahns Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
118,852
+50.0%
|
-
|
|
Feb 23
2021
|
Beverley Brown Chief Scientist |
BUY
Other acquisition or disposition
|
Indirect |
20,002
+50.0%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 800 shares |
|---|---|
| Conversion of derivative security | 5.72K shares |
| Bona fide gift | 7.7K shares |
|---|